Search Results - "Campiotti, L"

Imatinib (IM) discontinuation in chronic myeloid leukemia (CML): A pharmacogenetic score for patients with durable complete molecular response (CMR) by Campiotti, L, Ferrari, M, Orlandi, E.M, Suter, M.B, Squizzato, A, Guasti, L, Marino, F, Cosentino, M

“…An abstract of a study by Campiotti et al assessing the relationship between CMR and pharmacogenetics of imatinib (IM) is presented. We enrolled 59 consecutive…”
Get full text

Megakaryocytic blast crisis as first presentation of chronic myeloid leukemia by Campiotti, L., Grandi, A.M., Biotti, M.G., Ultori, C., Solbiati, F., Codari, R., Venco, A.

“…We describe an extremely rare case of megakaryocytic blast crisis as first presentation of chronic myeloid leukemia. The patient had a very high platelet count…”
Get full text

225 - Imatinib (IM) discontinuation in chronic myeloid leukemia (CML): A pharmacogenetic score for patients with durable complete molecular response (CMR) by Campiotti, L., Ferrari, M., Orlandi, E.M., Suter, M.B., Squizzato, A., Guasti, L., Marino, F., Cosentino, M.

Get full text

A randomized comparison of caspofungin versus antifungal prophylaxis according to investigator policy in acute leukaemia patients undergoing induction chemotherapy (PROFIL-C study) by Cattaneo, Chiara, Monte, Simona, Algarotti, Alessandra, Audisio, Ernesta, Borlenghi, Erika, Campiotti, Leonardo, Cerqui, Elisa, Fanizza, Caterina, Giuliani, Rachele, Micò, Caterina, Rocconi, Roberta, Salvi, Anna, Salvi, Flavia, Verga, Luisa, Levis, Alessandro, Lambertenghi Deliliers, Giorgio, Pogliani, Enrico M., Tognoni, Gianni, Rambaldi, Alessandro, Rossi, Giuseppe

“…Background Invasive fungal infections (IFIs) are considered a major problem among patients undergoing acute leukaemia (AL) induction treatment. PROphylaxis of…”
Get full text

PF227 PROGNOSTIC VALUE OF CLONAL HEMATOPOIESIS‐MUTATIONS DETECTED AT DIAGNOSIS IN ACUTE MYELOID LEUKEMIA PATIENTS WITH NORMAL KARYOTYPE by Caprioli, C., Spinelli, O., Salmoiraghi, S., Intermesoli, T., Zanghì, P., Cavagna, R., Michelato, A., Buklijas, K., Elidi, L., Delaini, F., Oldani, E., Gianfaldoni, G., Bosi, A., Marmont, F., Audisio, E., Ferrero, D., Terruzzi, E., De Paoli, L., Rossi, G., Borlenghi, E., Cavattoni, I., Tajana, M., Scattolin, A.M., Mattei, D., Corradini, P., Campiotti, L., Ciceri, F., Bernardi, M., Todisco, E., Cortelezzi, A., Cortelazzo, S., Falini, B., Pavoni, C., Bassan, R., Rambaldi, A., Lussana, F.

“…Background: Mutations in DNA and chromatin regulation genes have been associated with clonal hematopoiesis (CH) in older healthy subjects, but are also…”
Get full text

Limited Feasibility of Double Transplant Program: A Multicenter Study on 151 Multiple Myeloma Patients Aged≤65 Years by Corso, A., Mangiacavalli, S., Barbarano, L., Alessandrino, E.P., Cairoli, R., Zappasodi, P., Ferrari, D., Mazzone, A., Fava, S., Fiumanò, M., Frigerio, G., Isa, L., Luraschi, A., Montanara, S., Perego, M., Savarè, M., Uziel, L., Vismara, A., Campiotti, L., Morra, E., Lazzarino, M.

“…High dose therapy represents the gold standard therapy for newly diagnosed multiple myeloma (MM) patients (pts), with no definite agreement about the adoption…”
Get full text

Primary gastric lymphomas. Clinico-pathological study and evaluation of prognostic factors in 65 cases treated surgically by Pozzi, B, Hotz, A M, Feltri, M, Cornaggia, M, Campiotti, L, Bonato, M, Pinotti, G, Capella, C

“…Based on the histological criteria proposed by the REAL and adopted by the WHO Classification, 30 cases of MALT type lymphoma, 18 cases of diffuse large B cell…”
Get more information